# Summary Information 510(k) Summary

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. TheKO72440

1. Submitter   
name,   
address,   
contact

Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, New York 14626-5101 (585) 453-4041

Contact Person: Marlene A. Hanna

Preparation date

Date Special 510(k) prepared: August 29, 2007

3. Device name

Trade or Proprietary Name:   
VITROS Chemistry Products Ca Slides   
Common Name: calcium test   
Classification Name: Calcium test system (21 CFR 862.1145)

VITROS Chemistry Products Calibrator Kit 1 Common Name: calibrator Classification Name: Calibrator (21 CFR 862.1150)

4 Predicate device

The VITROS Chemistry Products Ca Slides (modified) and VITROS Chemistry Products Calibrator Kit 1 are substantially equivalent to the VITROS Chemistry Products Ca Slides (current slide) and VITROS Chemistry Products Calibrator Kit 1.

# 510(k) Summary, Continued

# 5. Device Description

The VITROS Chemistry Products Ca Slide assay is performed using the VITROS Chemistry Products Ca Slide and the VITROS Chemistry Products Calibrator Kit 1 on the VITROS Chemistry Systems. The VITROS Ca Slide is a multilayered, analytical element coated on a polyester support. All reactions necessary for a single quantitative measurement o calcium take place within the multi-ayered analytical element of a VITROS Chemistry Products Ca slide.

A drop of patient sample is deposited on the VITROS Ca Slide and is evenly distributed by the spreading layer to the underlying layers. The bound calcium is dissociated from binding proteins, allowing the calcium to penetrate through the spreading layer into the underlying reagent layer. In the reagent layer, the calcium forms a complex with Arsenazo II dye, causing a shift in the absorption maximum.

After incubation, the reflection density of the colored complex is measured spectrophotometrically by a VITROS Chemistry System. The amount of colored complex formed is proportional to the calcium concentration in the sample fluid. The test result is reported in milligrams per deciliter $\mathrm { ( m g / d L ) }$ or millimoles per liter (mmol/L).

VITROS Chemistry Products Calibrator Kit 1 contains three levels of lyophilized standards with corresponding diluents. The standards are prepared from processed bovine serum to which organic analytes, electrolytes, stabilizers, and preservatives have been added. The companion diluents are prepared from processed water to which inorganic salts have been added.

The VITROS Chemistry System and reagents are designed specifically for use with the VITROS Chemistry Products range of products.

6. Device intended use

VITROS Chemistry Products Ca Slides   
For in vitro diagnostic use only. VITROS Ca Slides quantitatively measure calcium (Ca) concentration in serum, plasma, and urine. VITROS Chemistry Products Calibrator Kit 1   
For in vitro diagnostic use only. VITROS Calibrator Kit 1 is used to calibrate the VITROS Chemistry Systems for the quantitative measurement of BUN/UREA, Ca, CREA, GLU, LAC, Li, Mg, PHOS, SALI, THEO, and URIC.

# 7Comparison to predicate device

The VITROS Chemistry Products Ca Slide (modified) and VITROS Chemistry Products Calibrator Kit 1 are substantially equivalent to VITROS Chemistry Products Ca Slide and ViTROS Chemistry Products Calibrator Kit 1, which were Cleared by the FDA for in vitro diagnostic use.

VITROS Chemistry Products Ca Slide: (K961226, cleared May 7, 1996) VITROS Chemistry Products Calibrator Kit 1: (K023876, cleared December 10, 2002).

Table 1 lists the characteristics of the tests performed using the VITROS Ca Slide (modified) and the VITROS Ca Slide (current).

Table 1. List of VITROS Chemistry Products Ca Slide Characteristics: Comparison to Predicate Device   
No modifications were made to VITROS Chemistry Products Calibrator Kit 1.   

<table><tr><td rowspan=1 colspan=1>DeviceCharacteristic</td><td rowspan=1 colspan=1>New DeviceVITROS Chemistry Products Ca Slide(Modified)</td><td rowspan=1 colspan=1>Predicate DeviceVITROS Chemistry Products CaSlide(Current)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>No Change.</td><td rowspan=1 colspan=1>For in vitro diagnostic use only.VITROS Ca Slides quantitatively measurecalcium (Ca) concentration in serum, plasma,and urine.</td></tr><tr><td rowspan=1 colspan=1>Fundamental scientifictechnology</td><td rowspan=1 colspan=1>No Change.</td><td rowspan=1 colspan=1>Dry, multilayered slide utilizingspectrophotometrics</td></tr><tr><td rowspan=1 colspan=1>Test Type</td><td rowspan=1 colspan=1>No Change.</td><td rowspan=1 colspan=1>Colorimetric</td></tr><tr><td rowspan=1 colspan=1>Reactive Ingredients per cm2</td><td rowspan=1 colspan=1>No Change.</td><td rowspan=1 colspan=1>Arsenazo III dye 60 Î¼g</td></tr><tr><td rowspan=1 colspan=1>Sample type</td><td rowspan=1 colspan=1>No Change.</td><td rowspan=1 colspan=1>Serum, plasma, urine.</td></tr><tr><td rowspan=1 colspan=1>Instrumentation</td><td rowspan=1 colspan=1>No Change.</td><td rowspan=1 colspan=1>VITROS 250, 550, 750, 950 and 5,1FSSeries Analyzers</td></tr><tr><td rowspan=1 colspan=1>Composition of theSpreading Layer* componentof the VITROS Ca Slide</td><td rowspan=1 colspan=1>TiO2: New SupplierCellulose Acetate: New lotEstane: Increased to 1.7 times the current level,i.e. 70% increase. Estane concentration iscorrelated to manufacturability of the VITROSCa Slide.Surfactants: No Change.</td><td rowspan=1 colspan=1>TiO2, Cellulose Acetate, Estane, Surfactants</td></tr><tr><td rowspan=1 colspan=1>Manufacturing ProcessChanges due to the increasedEstane level in the SpreadingLayer* Component of theVITROS Ca Slide</td><td rowspan=1 colspan=1>The increased concentration of Estane raisedthe viscosity, requiring modifications to thesolution delivery system and to the non-solventflow rate.</td><td rowspan=1 colspan=1>Current Manufacturing Process.</td></tr></table>

T Spr Lye th  aye    heisy   Slie o    eTeSa ve samp lui heryyers e VR  .

# 510(k) Summary, Continued

# Conclusions

The information presented in the premarket notification demonstrates that the performance of the VITROS Chemistry Products Ca Slides (modified) for use with human serum, plasma and urine is substantially equivalent to the cleared predicate device.

Equivalence was demonstrated using manufactured slides along with patient and quality control samples with measured calcium values spanning the assay range.

The information presented in the premarket notification provides a reasonable assurance that the VITROS Chemistry Products Ca Slides (modified) for use with human serum, plasma, and urine is safe and effective for the stated intended use.

# SEP 2 0 2007

Ortho-Clinical Diagnostics, Inc. c/o Marlene A. Hanna 100 Indigo Creek Drive Rochester, New York 14626-5101

Re: k072440 Trade/Device Name: VITROS $^ \mathrm { \textregistered }$ Chemistry Products Ca Slides VITROS $\textsuperscript { \textregistered }$ Chemistry Products Calibrator Kit 1 Regulation Number: 21 CFR $\ S$ 862.1145 Regulation Name: Calcium test system Regulatory Class: Class II Product Code: CJY, JIX Dated: August 29, 2007 Received: August 30, 2007

Dear Ms. Hanna:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in acordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus; permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0490. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address at   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Jean M.COopes, M.S. D.V.M. Yean M. Cooper, M.S., D.V.M.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and   
Radiological Health

# Indication for Use

Device Name: VITROS Chemistry Products Ca Slides

Indication For Use: For in vitro diagnostic use only. VITROS Ca Slides quantitatively measure calcium $\mathrm { ( C a ) }$ concentration in serum, plasma, and urine. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone disorders, chronic renal disease and tetany (intermittent muscular contractions or spasms).

# Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/69f36b3981a5b1307388add56159c7f48494b7c506f97f600774d4d36780c6d1.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indication for Use

510kKOT2440

Device Name: VITROS Chemistry Products Calibrator Kit 1

Indication For Use: For in vitro diagnostic use only. VITROS Calibrator Kit  is used to calibrate the VITROS Chemistry Systems for the quantitative measurement of BUN/UREA, Ca, CREA, GLU, LAC, Li, Mg, PHOS, SALI, THEO, and URIC.

# Concrec RH, Offic  IVi Dagosi Devivalution nd Safety OIVD

![](images/3e34dc5f136aa5599e010035baa04dc995c6772f06ce09832c0e4c93c0d5e2b4.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety